Recursion Pharmaceuticals (RXRX) stock valuation

$3.20 Nov 13, 2026 · market cap $1.4B

No estimate
i

Recursion Pharmaceuticals trades at $3.20. We don't have a valuation for it yet.

8 of 121 tracked investors hold it · Q2–Q3 2026 13F filings

Estimates from SEC filings and market data; the verdict is AI research. Not investment advice. Get the iPhone app · Get the Android app

5 AI analysts debate RXRXCreate free account →

Full open-source research report for RXRX on DeepValues Research (CC BY 4.0)